Month: November 2011

November 28, 2011
Inspiration initiates second trial of porcine FVIII

Inspiration Biopharmaceuticals, Inc. has announced the initiation of patient enrolment in the second of two pivotal studies in its OBI-1 Accur8 clinical trial program. This prospective, non-randomized, open-label study will evaluate the efficacy of OBI-1 for the treatment of serious bleeding episodes in patients with congential haemophilia A who have developed inhibitors against human FVIII. …

Read article
November 4, 2011
FEIBA prophylaxis tops on-demand treatment for joint bleeds

Prophylaxis with FEIBA (anti-inhibitor coagulant complex, AICC) significantly and safely decreased the frequency of joint and other bleeding events compared to on-demand therapy in patients with severe haemophilia A and factor VIII inhibitors, according to a study published this week in the New England Journal of Medicine. The investigator-initiated Prophylaxis with Factor Eight Inhibitor Bypassing …

Read article